Rimini Street, Inc. Deferred Foreign Income Tax Expense (Benefit)
Rimini Street, Inc. (RMNI) reported Deferred Foreign Income Tax Expense (Benefit) of -$79.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2026-02-19
- Rimini Street, Inc. deferred foreign income tax expense (benefit) for fiscal 2025 was -$79.00K.
- Rimini Street, Inc. deferred foreign income tax expense (benefit) for fiscal 2024 was -$163.00K.
- Rimini Street, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was -$98.00K.
- Rimini Street, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was -$580.00K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$79.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | -$163.00K 10-K · filed 2026-02-19 |
| 2023-12-31 | -$98.00K 10-K · filed 2026-02-19 |
| 2022-12-31 | -$580.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | -$44.00K 10-K · filed 2024-02-28 |
| 2020-12-31 | -$514.00K 10-K · filed 2023-03-01 |
| 2019-12-31 | -$337.00K 10-K · filed 2022-03-02 |
| 2018-12-31 | -$235.00K 10-K/A · filed 2021-05-10 |
| 2017-12-31 | -$124.00K 10-K · filed 2020-03-16 |
| 2016-12-31 | -$520.00K 10-K · filed 2019-03-14 |
| 2015-12-31 | -$55.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Claritev Corp (CTEV) | United States | $0.396B | -2.04 |
| Advantage Solutions Inc. (ADV) | United States | $0.435B | -2.00 |
| International Money Express, Inc. (IMXI) | United States | $0.320B | 23.44 |
| Outdoor Holding Co (POWW) | United States | $0.270B | 40.73 |
| CONDUENT Inc (CNDT) | United States | $0.253B | -1.00 |
| DHI GROUP, INC. (DHX) | United States | $0.205B | 132.15 |
| Phreesia, Inc. (PHR) | United States | $0.621B | 63.46 |
| Priority Technology Holdings, Inc. (PRTH) | United States | $0.643B | 9.77 |
| TEN Holdings, Inc. (XHLD) | United States | $0.152B | |
| OptimizeRx Corp (OPRX) | United States | $0.149B | 23.33 |